Jupiter Neurosciences (JUNS) Research & Development (2023 - 2026)

Jupiter Neurosciences (JUNS) has reported Research & Development for 4 consecutive years, with $600353.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development fell 20.95% year-over-year to $600353.0 in Q2 2026; TTM through Jun 2026 was $2.2 million, a 46.15% increase from a year earlier, with the FY2025 full-year figure at $2.1 million, up 323.53% from the prior year.
• Research & Development was $600353.0 for Q2 2026 at Jupiter Neurosciences, up from $43684.0 in the prior quarter.
• Over five years, Research & Development peaked at $816697.0 in Q3 2025 and troughed at $43684.0 in Q4 2025.
• A 4-year average of $333070.5 and a median of $239458.0 in 2023 frame the typical range for Research & Development.
• The widest YoY moves for Research & Development: up 788.57% in 2025, down 78.27% in 2025.
• Over 4 years, Research & Development stood at $244730.0 in 2023, then slipped by 17.87% to $201005.0 in 2024, then tumbled by 78.27% to $43684.0 in 2025, then surged by 1274.31% to $600353.0 in 2026.
• The last three Research & Development figures came in at $600353.0 (Q2 2026), $43684.0 (Q4 2025), and $816697.0 (Q3 2025), per Business Quant data.